Neuroone Medical Technologies (NMTC) Revenue (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Revenue for 13 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 16.34% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (up 42.84% YoY), and the FY2025 full-year result was $9.1 million, up 163.47% from the prior year.
• Revenue improved to $2.0 million in Q2 2026 per NMTC's latest filing, from $1.9 million in the prior quarter.
• Across five years, Revenue topped out at $3.3 million in Q4 2024 and bottomed at $32049.0 in Q2 2022.
• Historically, Revenue has averaged $1.2 million across 5 years, with a median of $901712.5 in 2023.
• The sharpest annual moves came in 2023 and 2024: Revenue soared 1865.45% in 2023, then slumped 63.29% in 2024.
• Over 5 years, Revenue stood at $114579.0 in 2022, then jumped by 753.25% to $977649.0 in 2023, then jumped by 234.9% to $3.3 million in 2024, then dropped by 11.65% to $2.9 million in 2025, then slumped by 31.79% to $2.0 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $2.0 million, $1.9 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.